The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
SwanBio Therapeutics, a US-based gene therapy developer focused on adeno-associated virus-based treatments for inherited neurological conditions, has closed a $56m series B round co-led by Syncona and Mass General Brigham Ventures, the investment arm of health system Mass General Brigham. The Harvard University spinout has bow raised $133m altogether, after Syncona had already contributed to a $77m series A round in 2020.
Nikola Labs, a US-based provider of sensor-based reliability technology to remotely monitor manufacturing infrastructure, has raised $20m…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
